Fluvac Innovator EHV-4/1This page contains information on Fluvac Innovator EHV-4/1 for veterinary use.
The information provided typically includes the following:
- Fluvac Innovator EHV-4/1 Indications
- Warnings and cautions for Fluvac Innovator EHV-4/1
- Direction and dosage information for Fluvac Innovator EHV-4/1
Fluvac Innovator EHV-4/1This treatment applies to the following species:
Equine Rhinopneumonitis-Influenza Vaccine
Fluvac Innovator EHV-4/1 Indications
For intramuscular vaccination of healthy horses as an aid in the prevention of equine rhinopneumonitis due to types 1 and 4 viruses, and equine influenza due to type A2 viruses. Fluvac Innovator EHV-4/1 contains equine influenza virus A/equine-2/Kentucky/97 (H3N8)-American Lineage. Efficacy has been demonstrated by challenge with equine influenza virus A/equine-2/Ohio/03 (H3N8)-American Lineage.
Dosage and AdministrationHorses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually.
Fluvac Innovator EHV-4/1 Caution
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
For Veterinary Use Only
Remove serial number and expiration date label and place on the animal’s medical chart.
U.S. Vet. License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
NAC No.: 3690288.3
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Fluvac Innovator EHV-4/1 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-07-10